Bluestone Pharma
Bluestone Pharma GmbH is a Switzerland-based private company that develops and distributes the Bactoblis brand of oral probiotic lozenges and sachets through pharmacy channels in 30+ international markets, with demand driven by local Health Care Practitioner recommendations.
- Company typePrivate
- Founded2014
- HeadquartersBaar, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bluestone Pharma does
Bluestone Pharma GmbH is a Switzerland-based, privately held company that develops, manufactures, and distributes probiotic formulations specifically targeted at the oral microbiome. Founded in 2014 and headquartered in Baar, Switzerland, the company sells its products in more than 30 international markets, primarily through pharmacy channels, with local Health Care Practitioners functioning as the principal demand-generation mechanism. The company describes itself as first-to-market in pharmacy-distributed medical probiotics for oral health and as a category benchmark-setter for more than a decade.
The company's commercial offering is concentrated in a single brand, Bactoblis, which is sold as oral probiotic lozenges and sachets. Underlying technology centers on proprietary probiotic manufacturing processes designed to ensure stability, safety, and efficacy from raw ingredients through to finished product, with positioning anchored in clinical relevance to unmet patient needs in oral care. The company holds registered trademarks for both the BLUESTONE PHARMA corporate brand and the Bactoblis product brand, and it received the Nutra Ingredients Award 2025 in the Innovation / R&D category, signaling industry recognition of its formulation work.
Bluestone Pharma operates a sales-led, B2B/B2C hybrid model: products are sold through pharmacy retail while demand is shaped upstream by Health Care Practitioner recommendations. The company has a wholly-owned sales subsidiary, Bluestone Pharma Spain S.L., based in Sitges, to support European operations. No public pricing, revenue, funding history, cap table, or named enterprise customers are disclosed in the available data, and the business appears to be founder-held and self-funded.
Bluestone Pharma firmographics
Firmographics- Name
- Bluestone Pharma
- Legal name
- Bluestone Pharma GmbH
- Website
- https://bluestone-pharma.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bluestone Pharma GmbH is a Switzerland-based private company that develops and distributes the Bactoblis brand of oral probiotic lozenges and sachets through pharmacy channels in 30+ international markets, with demand driven by local Health Care Practitioner recommendations.
- Ownership category
- akta.pro rank
Where Bluestone Pharma is headquartered
LocationHeadquarters
- HQ city
- Baar
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
Bluestone Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Probiotic Product Sales: Manufactures and sells innovative probiotic formulations (including Bactoblis brand products such as lozenges and sachets) through pharmacy channels across more than 30 international markets. Revenue generated through product sales with local Health Care Practitioners driving demand.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Bluestone Pharma product offering
Product offeringCore offering
Bluestone Pharma develops and manufactures innovative probiotic formulations focused on the oral microbiome, marketed under the Bactoblis brand as lozenges and sachets. Products are sold through pharmacy channels across more than 30 international markets, with local Health Care Practitioners driving demand and prescription behavior.
Product overview
Bluestone Pharma operates as an international operating company based in Switzerland developing and manufacturing innovative probiotic formulations focused on the oral microbiome, selling in more than 30 markets. Their product portfolio centers on Bactoblis, their core medical probiotic brand offering lozenges and sachets for oral microbiome support. For more than a decade, they have positioned themselves as pioneers in medical probiotics with pharmacy-first market entry, supported by local Healthcare Practitioners.
Differentiator
Problem solved
Functional benefit
Brands
- Bactoblis: Probiotic product brand focused on oral microbiome health, marketed through the company's pharmacy channel.
Products and services
- Bactoblis
Companies that use Bluestone Pharma
Customer profileSegments3 records
Ideal customer profiles2 records
Bluestone Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Bluestone Pharma partnerships and signals
Strategic signalScale indicators3 records
Recent moves4 records
Expansion highlights4 records
Bluestone Pharma competitors and assessment
Company assessmentOthers
- Chr. Hansen (now Novonesis): Global bioscience company and major probiotic strain supplier to many CPG and supplement brands. Comparable as the upstream strain/probiotic ingredient ecosystem participant that both supplies and competes with downstream brands like Bluestone.
- Lallemand Health Solutions: Canadian probiotic ingredient manufacturer with documented oral and gut health strains. Comparable as an enabling ecosystem participant supplying probiotic raw materials and finished formulations in the same category Bluestone serves.
Emerging players
- Hyperbiotics: US-based direct-to-consumer and pharmacy probiotic brand featuring a PRO-Dental oral probiotic SKU. Comparable as a smaller, brand-led probiotic company operating in the oral microbiome space with similar product formats (lozenges/sachets).
Direct peers
- BLIS Technologies: New Zealand-based developer of BLIS K12 (Streptococcus salivarius K12), the foundational strain behind many oral probiotic products including Bactoblis. Closest direct competitor in the oral microbiome probiotic niche with overlapping strain technology and pharmacy-channel positioning.
- BioGaia: Swedish probiotics specialist with BioGaia Prodentis (L. reuteri) targeting oral health. Comparable as a clinically-substantiated, HCP-endorsed oral probiotic brand sold through pharmacy channels globally.
- BioGaia (Prodentis line): Note: see BioGaia above. BioGaia Prodentis is the most directly competing oral-health probiotic line with shared clinical, pharmacy, and HCP-led distribution model.
- Winclove Probiotics: Dutch probiotic formulation company offering multi-strain oral microbiome products (e.g., Ecologic Oral). Comparable as a science-driven probiotics manufacturer selling finished formulations into healthcare/pharmacy channels.
Broad incumbents
- Yakult: Japanese global probiotics giant with deep pharmacy and healthcare channel presence in 40+ countries. Comparable as a large, established probiotics brand that defines category norms and competes for HCP endorsement and consumer shelf space.
- Culturelle (i-Health): Mass-market probiotic brand owned by i-Health (Ferrosan/Chr. Hansen lineage). Comparable as a pharmacy-distributed probiotic consumer brand with adjacent oral/dental extensions (Culturelle Dental) competing for the same shelf.
- Danone (Probiotic Dairy & Supplements): Multinational food and dairy giant operating probiotic brands (Actimel, Activia) and adjacent supplement portfolios. Comparable as a deep-pocketed incumbent able to leverage scientific claims and global retail relationships to contest the oral probiotic niche.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Bluestone Pharma social profiles
Digital presenceBluestone Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bluestone Pharma leadership team
Management profileNumber of profiles
Bluestone Pharma subsidiaries and ownership
Company hierarchySubsidiaries1 record
Bluestone Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bluestone Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bluestone Pharma
What does Bluestone Pharma do?
Bluestone Pharma develops and manufactures innovative probiotic formulations focused on the oral microbiome, marketed under the Bactoblis brand as lozenges and sachets. Products are sold through pharmacy channels across more than 30 international markets, with local Health Care Practitioners driving demand and prescription behavior.
Is Bluestone Pharma a public or private company?
Bluestone Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bluestone Pharma founded?
Bluestone Pharma was founded in 2014. It employs 11 to 50 people.
Where is Bluestone Pharma based?
Bluestone Pharma is headquartered in Baar, Switzerland, in the Europe region.
How does Bluestone Pharma make money?
One revenue line is on record: probiotic Product Sales.
Who are Bluestone Pharma's main competitors?
Others on record are Chr. Hansen (now Novonesis) and Lallemand Health Solutions. Hyperbiotics is listed as an emerging player. Direct peers are BLIS Technologies, BioGaia, BioGaia (Prodentis line) and Winclove Probiotics. Broad incumbents are Yakult, Culturelle (i-Health) and Danone (Probiotic Dairy & Supplements).
Does Bluestone Pharma have an API?
No public API is recorded for Bluestone Pharma.